Use of complementary/alternative medicine by men diagnosed with prostate cancer: Prevalence and characteristics

Urology

Volumn 62, Issue 5, 2003, Pages 849-853

  Boon, Heather ^a   Westlake, Kathleen ^b   Stewart, Moira ^b   Gray, Ross ^b   Fleshner, Neil ^b   Gavin, Alan ^b   Brown, Judith Belle ^b   Goel, Vivek ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GARLIC EXTRACT; LYCOPENE; SABAL EXTRACT; SELENIUM; VITAMIN D; ZINC;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANADA; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DEMOGRAPHY; DIET SUPPLEMENTATION; DIET THERAPY; GARLIC; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; POSTAL MAIL; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RANDOMIZATION; SAMPLING; SOCIOECONOMICS; SOYBEAN; TEA;

EID: 0242495792     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00668-X     Document Type: Article

References (15)

1. Nam R.K., Fleshner N., Rakovitch E., et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients an epidemiological analysis. J Urol. 161:1999;1521-1524.
2. Kao G.D., Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer. 88:2000;615-619.
3. Wilkinson S., Gomella L.G., Smith J.A., et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 168:2002;2505-2509.
4. Lippert M., McClain R., Boyd J.C., et al. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer. 86:1999;2642-2648.
5. Defining and describing complementary and alternative medicine. Alternat Ther Health Med. 3:1997;49-57.
6. NIH National Centre for Complementary and Alternative Medicine: Classification of complementary and alternative medical practices. NCCAM Publication No. D156, 2002. Available at http://nccam.nih.gov/health/whatiscam/ #3. Accessed June 2002.
7. Cancer Care Ontario, The Ontario Cancer Registry: Introduction, in Cancer Care Ontario, 2002. Available at: http://www.cancercare.on.ca/ocr/ ontcancerreg.html. Accessed May 2003.
8. Boon H., Stewart M., Kennard M.A., et al. The use of complementary/ alternative medicine by breast cancer survivors in Ontario prevalence and perceptions. J Clin Oncol. 18:2000;2515-2521.
9. Boon H, Brown JB, Gavin A, et al. Men with prostate cancer: making decisions about complementary/alternative medicine. Med Dec Making (in press).
10. Hall J., Bissonette E., Boyd J., et al. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent results of a pilot study. BJU Int. 91:2003;603-607.
11. Boon H., Verhoef M. Complementary and alternative medicine a Canadian perspective. Edzard E. The Desktop Guide to Complementary and Alternative Medicine. 2001;362-373 Mosby, Toronto.
12. Yates P., Beadle G., Clavarino A., et al. Patients with terminal cancer who use alternative therapies their beliefs and practices. Sociol Health Illness. 15:1993;199-217.
13. Lerner I.J., Kennedy B.J. The prevalence of questionable methods of cancer treatment in the United States. CA-A Cancer J Clin. 42:1992;181-191.
14. Risberg T., Lund E., Wist E., et al. The use of non-proven therapy among patients treated in Norwegian oncology departments a cross-sectional national multicentre study. Eur J Cancer. 31A:1995;1785-1789.
15. Cassileth B.R., Lusk E.J., Strouse T.B., et al. Contemporary unorthodox treatments in cancer medicine. Ann Intern Med. 101:1984;105-112.